Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
Nimotuzumab inoperable esophageal epithelial tumors, Phase IV
30/06/2016
Registered
Nimotuzumab-pancreatic cancer-adults-Phase IV.
30/04/2017
Registered
Patients with non small cells lung cancer (NSCLC) and brain metastasis.
2010-12-29
Registered
Phase I/II trial with the mutein no alfa of IL-2
03/02/2017
Registered outdated
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer.
23/05/2014
Registered
Phyisician Led CIMAvax-EGF lung biomarkers
11/03/2021
Registered outdated
Post EUA study of Itolizumab in COVID-19
21/03/2022
Registered outdated
Predictor of response with CIMAvax EGF© in NSCLC Phase III
29/01/2016
Registered
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX
21/05/2021
Registered outdated
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory
09/07/2018
Registered
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer.
26/05/2014
Registered
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients
15/12/2015
Registered
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer
08/07/2015
Registered
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma
05/11/2013
Registered outdated
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations
22/05/2021
Registered outdated
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III.
01/10/2020
Registered outdated
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors
17/02/2017
Registered
T1h in severe psoriasis-expanded access program (PUCE)
2012-07-20
Registered
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients
2010-12-24
Registered
Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab
12/05/2020
Registered outdated
« first
‹ previous
1
2
3
4
5
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform